Sabra Healthcare REIT, Inc. Form 4 Filings

Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. Smith Darrin reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. (SBRA) reported that Executive VP, CIO & Secretary Darrin Smith received a grant of 495 stock units of common stock on August 31, 2026 as a dividend equivalent on previously granted units under the 2009 Performance Incentive Plan. Following this award, he directly holds 116,919 stock units and shares, including 34,182 stock units payable in common stock on a one-for-one basis, all subject to the same vesting terms as the original units. No Rule 10b5-1 trading plan is reported.

Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. (SBRA) director Jeffrey A. Malehorn received a grant of 791 stock units of common stock-equivalent on August 31, 2026 as a dividend-equivalent credit under the company’s 2009 Performance Incentive Plan. Following this award, he holds 117,137 stock units, including unvested and deferred units.

Sabra Health Care REIT, Inc. (SBRA) reported that director Ann Kono acquired 791 stock units of common stock on August 31, 2026 as a dividend equivalent credit under Sabra’s 2009 Performance Incentive Plan. Following this award, she directly holds 68,977 stock units, each representing the right to receive one share of common stock.

Sabra Health Care REIT, Inc. (SBRA) reported that director Lynne S. Katzmann received a grant of 791 stock units of common stock on August 31, 2026, as a grant/award acquisition with no cash price per share. The stock units were credited as dividend equivalent payments on previously granted stock units outstanding under Sabra’s 2009 Performance Incentive Plan and will vest and become payable on the same terms as the original stock units. Following this award, Katzmann holds a reported total of 86,912 stock units, including 7,027 unvested stock units and 47,553 stock units that have vested but for which payment has been deferred, with each stock unit representing the right to receive one share of Sabra common stock.

Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. FOSTER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Michael J. Foster reported receiving a grant of 791 stock units tied to common stock on August 31, 2026. According to the company’s equity plan, these units were credited as dividend equivalent payments on previously granted stock units and will vest and be paid on the same schedule as those original units.

After this award, Foster holds 82,834 stock units directly, including 7,027 unvested stock units and 47,553 vested but deferred stock units, each representing the right to receive one share of common stock. He also has 42,411.745 shares held indirectly through a 401(k) plan. No transactions are reported as made under a Rule 10b5-1 trading plan.

Sabra Health Care REIT, Inc. (SBRA) director Catherine Cusack reported an acquisition of 791 stock units of common stock on August 31, 2026, as a grant or award. The units were credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan.

After this credit, Cusack directly holds 82,847 stock units, including 7,027 unvested stock units and 47,553 vested stock units for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra common stock.

Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. (SBRA) director Craig A. Barbarosh received an automatic grant of 791 stock units of common stock on August 31, 2026, as dividend equivalent payments on previously granted stock units under the 2009 Performance Incentive Plan. Following this grant, he holds 54,580 stock units directly, consisting of 7,027 unvested units and 47,553 vested but deferred units, each representing the right to receive one share of common stock, plus 104,453 shares held indirectly by The Barbarosh Family Trust. No Rule 10b5-1 trading plan is reported.

Sabra Health Care REIT, Inc. (SBRA) reported that Executive VP & CAO Jessica Flores received an award of 382 stock units of common stock on August 31, 2026, as a grant or award acquisition. These units were credited as dividend equivalent payments on previously granted stock units under the 2009 Performance Incentive Plan.

After this award, Flores holds 72,476 stock units/shares-equivalent directly, including 26,294 stock units that will be settled on a one-for-one basis in Sabra common shares under the same plan terms.

Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. Costa Michael Lourenco reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. (SBRA) reported that Executive VP, CFO & Treasurer Michael Lourenco received a grant of 4,158 stock units of common stock on August 31, 2026. These units were credited as dividend equivalent payments on previously granted stock units and will vest and be paid on the same terms as the original awards.

After this grant, Lourenco holds 469,879 stock units directly, including 286,773 stock units that will settle one-for-one in common shares upon vesting, plus indirect holdings of 784 shares in his IRA and 207 shares in his spouse’s IRA. No Rule 10b5-1 trading plan is reported.

Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. MATROS RICHARD K reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. (SBRA) reported that Chair, CEO and President Richard K. Matros received a grant of 13,867 stock units of common stock on August 31, 2026 as a dividend-equivalent credit on previously granted stock units under the 2009 Performance Incentive Plan. These units will vest and be settled in common shares on the same terms as the original awards, bringing his directly held stock units to 956,268 shares, with an additional 1,857,686 shares held indirectly through the R&A Matros Revocable Trust. No Rule 10b5-1 trading plan is reported.

Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Jeffrey A. Malehorn received an equity grant of 8,310 restricted stock units of common stock as compensation. The award was granted under Sabra’s 2009 Performance Incentive Plan and carries no purchase price.

The units vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. After this grant, Malehorn has beneficial ownership of 116,346 shares/units, including 8,310 unvested stock units and 55,016 stock units that have vested but with payment deferred, each unit representing one share of common stock.

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Ann Kono received an equity award of 8,310 restricted stock units of common stock as compensation. The grant was made at no cash cost to her and is structured to vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders' meeting.

Each unit represents the right to receive one share of Sabra’s common stock. Following this grant, Kono has an aggregate 68,186 stock units, including the 8,310 unvested units from this award and 55,016 units that have already vested but for which share delivery has been deferred.

KATZMANN LYNNE S reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 8,310 restricted stock units of Common Stock at no cash cost, as part of the company’s 2009 Performance Incentive Plan. These units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.

Each stock unit represents the right to receive one share of common stock. Following this award, Katzmann directly holds 86,121 stock units, including 8,310 unvested units and 55,016 units that have vested but for which payment has been deferred.

FOSTER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Michael J. Foster reported a new equity award and updated holdings. He received a grant of 8,310 shares of common stock as a restricted stock unit award at a stated price of $0.00 per share, increasing his direct ownership to 82,043 shares after the award. The units were granted under the company’s 2009 Performance Incentive Plan and will vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. The filing also shows 42,411.745 shares held indirectly through a 401(k) plan and notes that his equity mix includes 8,310 unvested stock units and 55,016 vested but deferred stock units, each representing the right to receive one share of common stock.

Cusack Catherine reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Catherine Cusack received a grant of 8,310 restricted stock units of Common Stock. The grant was made at no cash cost per share and increases her direct holdings to 82,056 shares and stock units in total following the transaction.

The restricted stock units were granted under Sabra’s 2009 Performance Incentive Plan. According to the terms, they vest in equal monthly installments beginning on July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.

Footnote disclosure indicates her holdings include 8,310 unvested stock units from this grant and 55,016 stock units that have already vested but for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s Common Stock.

Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Craig A. Barbarosh reported an equity compensation grant rather than an open-market trade. He received 8,310 restricted stock units of common stock under the company’s 2009 Performance Incentive Plan at no cash cost.

The units vest in equal monthly installments beginning July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. Following this grant, he holds 63,326 stock units directly, consisting of 8,310 unvested units and 55,016 vested units with payment deferred, each representing one share of common stock. He also reports 94,916 shares held indirectly through The Barbarosh Family Trust.

Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Jeffrey A. Malehorn received 817 stock units as a compensation-related award. The units were credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan, with no cash paid by Malehorn. These new units vest and pay on the same schedule as the original awards.

After this grant, Malehorn directly holds 108,036 stock units or shares-linked units, including 726 unvested stock units and 54,290 vested stock units whose payment has been deferred. Each stock unit represents the right to receive one share of Sabra common stock.

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Ann Kono received an award of 817 common stock units on May 29, 2026. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.

Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same schedule as the original awards. Following this grant, Kono directly holds 59,876 stock units, including 726 unvested units and 54,290 vested units for which payment has been deferred.

Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 817 stock units of common stock on May 29, 2026. The award was credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carries no cash exercise price.

Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same terms as the original units they relate to. After this credit, Katzmann holds 77,811 stock units in total, including 726 unvested units and 54,290 vested units with payment deferred.

Sabra Health Care REIT director Michael J. Foster reported routine share and stock unit changes. He made a bona fide gift of 500 shares of common stock and received 817 additional stock units credited as dividend equivalent payments under the company’s 2009 Performance Incentive Plan.

After these transactions, he directly holds 73,733 shares of common stock and indirectly holds 42,411.745 shares through a 401(k) plan. Footnotes also note 726 unvested stock units and 54,290 vested but deferred stock units, each representing the right to receive one share of common stock.

Sabra Health Care REIT, Inc. director Catherine Cusack reported an acquisition of 817 stock units of Common Stock on the basis of dividend equivalent payments. These units were credited under the company’s 2009 Performance Incentive Plan at the market value on the dividend payment date.

Each stock unit represents the right to receive one share of Common Stock. After this grant, Cusack directly holds 73,746 stock units, including 726 unvested units and 54,290 units that have vested but for which payment has been deferred.

Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Craig A. Barbarosh reported routine equity compensation rather than an open‑market trade. He received an award of 817 common stock units at a price of $0.0000 per unit, credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan.

Following this grant, Barbarosh holds 55,016 stock units directly and 94,916 shares indirectly through The Barbarosh Family Trust. The new units will vest and be paid on the same schedule as the original stock units they track, with each unit representing the right to receive one Sabra common share.

Sabra Health Care REIT, Inc. reported that Executive VP & CAO Jessica Flores acquired 385 shares of common stock on May 29, 2026 through a stock unit award valued at $0.00 per share. These stock units were credited as dividend equivalent payments on previously granted units under the company’s 2009 Performance Incentive Plan.

After this grant, she directly holds 72,094 shares of common stock in total. This amount includes 25,912 stock units that will be settled on a one-for-one basis in Sabra common shares, vesting on the same schedule as the original awards. The transaction reflects routine equity compensation rather than an open-market purchase or sale.

Sabra Health Care REIT, Inc. Executive VP, CIO & Secretary Darrin Smith reported a compensation-related stock grant. On May 29, 2026, he acquired 501 shares of Common Stock at no cost through stock units credited as dividend equivalent payments on previously granted units.

After this award, Smith directly holds 116,424 shares, including 33,687 stock units that will be settled one-for-one in common shares under the company’s 2009 Performance Incentive Plan. This filing reflects routine equity compensation rather than an open-market purchase or sale.

Sabra Health Care REIT, Inc. Executive VP, CFO & Treasurer Michael Lourenco received an award of 4,200 common stock units credited as dividend equivalents on previously granted stock units, at a stated price of $0.0000 per share. These units will vest and be paid on the same schedule as the original awards. After this acquisition, he holds 465,721 shares and stock units directly, including 282,615 stock units that will settle one-for-one in common shares, plus indirect holdings of 207 shares in his spouse’s IRA and 784 shares in his own IRA.

MATROS RICHARD K reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director and CEO Richard K. Matros reported a compensation-related equity award. He received 14,003 stock units of common stock on a grant or award basis at $0.00 per unit, increasing his direct holdings to 942,401 shares.

Footnotes explain these are stock units credited as dividend equivalent payments on previously granted units under the company’s 2009 Performance Incentive Plan. The new units will vest and be paid in shares on the same schedule as the original units. Matros also reports 1,857,686 shares held indirectly through the R&A Matros Revocable Trust.

Sabra Health Care REIT director Michael J. Foster reported routine equity holdings and a small charitable-style transfer. The Form 4 shows a bona fide gift of 490 shares of Common Stock on May 27, 2026 at a stated price of $0.0000 per share. After this gift, he directly holds 73,416 shares of Common Stock. A separate entry reflects 42,411.745 shares held indirectly through a 401(k) Plan, representing retirement-plan ownership. A footnote notes an additional 715 unvested stock units and 53,484 vested stock units with deferred payment, each unit corresponding to one share of Sabra’s Common Stock, highlighting further equity-based compensation exposure.

Sabra Health Care REIT, Inc. director Michael J. Foster reported an insider transaction involving the company’s Common Stock. On May 22, 2026, he made a bona fide gift of 813 shares of Common Stock at a reported price of $0.00 per share. After this gift, Foster directly held 73,906 shares of Common Stock. He also indirectly held 42,411.745 shares of Common Stock through a 401(k) Plan. A footnote further states that his holdings include 715 unvested stock units and 53,484 vested but deferred stock units, each representing the right to receive one share of Common Stock.

Sabra Health Care REIT, Inc. Executive VP & CAO Jessica Flores reported an open-market sale of 15,231 shares of common stock on March 25, 2026 at a weighted average price of $19.86 per share, with individual trades ranging from $19.85 to $19.89.

After this transaction, she directly holds 71,709 shares, which include 25,527 stock units that will settle on a one-for-one basis in Sabra common stock.

Sabra Health Care REIT, Inc. director Jeffrey A. Malehorn reported an automatic acquisition of 781 common stock units on February 27, 2026. These units were credited as dividend-equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carried no purchase price.

After this transaction, Malehorn directly holds 107,219 common stock units, including 2,854 unvested units and 51,345 units that have vested but with payment deferred. Each stock unit represents the right to receive one share of Sabra’s common stock, following the original grant’s vesting and payment terms.

Sabra Health Care REIT, Inc. director Ann Kono reported an acquisition of 781 shares of common stock on a Form 4. These were stock units credited as dividend-equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, at a price of $0 per unit.

After this grant, she holds a total of 59,059 stock units, including 2,854 unvested units and 51,345 units that have vested but whose payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s common stock.

Sabra Health Care REIT, Inc. director Lynne S. Katzmann acquired 781 common stock units on February 27, 2026 as a grant credited in the form of dividend-equivalent payments under the company’s 2009 Performance Incentive Plan. The units were calculated using the market value of Sabra’s common stock on the dividend payment date and were issued at a price of $0.00 per unit.

After this award, Katzmann directly holds a total of 76,994 stock units. This total includes 2,854 unvested stock units and 51,345 stock units that have already vested but for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s common stock, and the new units will vest and become payable on the same terms as the original stock units they track.

Sabra Health Care REIT director Michael J. Foster reported an acquisition of stock units tied to common stock. On February 27, 2026, he was credited with 781 stock units as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, at a stated price of $0.00 per unit.

These new units will vest and become payable on the same schedule as the original stock units they track. After this credit, Foster directly holds 74,719 shares of common stock, which include 2,854 unvested stock units and 51,345 vested stock units with deferred payment, each representing the right to receive one share. He also indirectly holds 42,411.745 shares through a 401(k) plan.

Catherine Cusack, a director of Sabra Health Care REIT, Inc., reported an acquisition of 781 shares of common stock on the basis of dividend equivalent payments on previously granted stock units. The award was priced at $0.00 per share, reflecting a stock unit credit rather than a cash purchase.

After this transaction, Cusack’s direct holdings increased to 72,929 stock units and shares, including 2,854 unvested stock units and 51,345 vested stock units with deferred payment. Each stock unit represents the right to receive one share of Sabra’s common stock under the company’s 2009 Performance Incentive Plan.

Sabra Health Care REIT, Inc. reported that director Craig A. Barbarosh acquired 781 common stock units on February 27, 2026 as a grant/award. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan at the market value on the dividend date.

After this award, Barbarosh directly holds 54,199 common stock units, including 2,854 unvested units and 51,345 vested units whose payment has been deferred. Each unit represents the right to receive one share of common stock. He also indirectly holds 94,916 shares through The Barbarosh Family Trust.

Sabra Health Care REIT, Inc. Executive VP & CAO Jessica Flores reported an acquisition of 368 shares of common stock on February 27, 2026. The transaction was coded as a grant or award, with a price of $0.00 per share, reflecting stock units rather than a market purchase.

According to the footnotes, these units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and will vest and pay out on the same schedule as the original awards. After this award, Flores directly holds a total of 86,940 shares/units, including 25,527 stock units that will settle on a one-for-one basis in common shares.

Sabra Health Care REIT, Inc. reported that Executive VP, CIO & Secretary Darrin Smith acquired 478 common stock units on February 27, 2026 as a grant/award. These units were credited as dividend-equivalent stock units based on the market value on the dividend payment date and carry no cash purchase price.

After this award, Smith directly holds 115,923 common shares/units, including 33,186 stock units that will settle one-for-one in Sabra common stock. The new dividend-equivalent units will vest and become payable on the same schedule as the original stock units they track.

Sabra Health Care REIT, Inc. Executive VP, CFO & Treasurer Michael Lourenco reported an acquisition of 4,005 shares of common stock on February 27, 2026. These reflect stock units credited as dividend equivalent payments on previously granted stock units under the 2009 Performance Incentive Plan and will vest and pay out on the same schedule as the related awards.

After this grant, he directly holds 461,521 shares of common stock, which includes 278,415 stock units that will settle one-for-one in common shares. He also has indirect holdings of 784 shares through his IRA and 207 shares through his spouse's IRA.

Sabra Health Care REIT, Inc. reported that Chair, CEO and President Richard K. Matros acquired 13,358 common stock units on February 27, 2026 as a grant or award. The units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.

These stock units will vest and be paid in shares of common stock on the same schedule as the original awards, on a one-for-one basis. Following this acquisition, Matros directly holds 928,398 common shares, and indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust.

Sabra Health Care REIT's Executive VP & CAO Jessica Flores reported equity compensation activity on February 10, 2026. She acquired 3,198 shares of common stock at $0 through vesting of funds-from-operations-based stock units granted under the 2009 Performance Incentive Plan.

On the same date, 1,172 shares were disposed of at $19.15 to satisfy tax withholding obligations related to restricted stock unit payouts. After these transactions, she directly owned 86,572 common shares, including 25,159 stock units that will settle one-for-one in common stock.

Sabra Health Care REIT, Inc. executive Darrin Smith reported performance-based equity awards and related tax share withholding. On February 10, 2026, he acquired 5,483 shares from FFO-based units and 14,088 shares from annual bonus PSUs, both vesting at no cash cost. The company withheld 2,927 and 6,390 shares at $19.15 per share to satisfy tax obligations. Following these transactions, he directly holds 115,445 shares of common stock, which includes 32,708 stock units payable one-for-one in shares upon settlement.

Sabra Health Care REIT, Inc.’s Executive VP, CFO & Treasurer Michael Lourenco Costa reported acquiring 22,848 shares of common stock on February 10, 2026 through vesting of performance-based stock units granted under the company’s 2009 Performance Incentive Plan.

The award was tied to funds-from-operations performance for the period from January 1, 2025 to December 31, 2025, with the compensation committee determining 90.8% of the target was earned, including 4,803 shares from dividend equivalents. Following this transaction, Costa directly beneficially owns 457,516 common shares, and the vested units are scheduled to be settled in shares on January 4, 2027, subject to earlier payment upon death, disability, or change of control.

Sabra Health Care REIT, Inc. Chair, CEO and President Richard K. Matros acquired 85,160 shares of common stock on February 10, 2026 at a price of $0 per share through the vesting of previously granted stock units. Following this award, he directly owns 915,040 common shares and indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust.

The vested shares relate to funds from operations-based stock units granted on December 27, 2022. The Compensation Committee determined that 90.8% of the target performance for the period from January 1, 2025 to December 31, 2025 was achieved, triggering immediate vesting. The vested units will be settled on a one-for-one basis in common shares on January 4, 2027, subject to earlier settlement upon death, disability or change of control.

Sabra Health Care REIT, Inc.’s Executive VP & CAO, Jessica Flores, reported equity award activity in the company’s common stock. On January 8, 2026, she acquired 7,996 shares at $0 upon vesting of performance-based stock units granted under the 2009 Performance Incentive Plan, including shares from dividend equivalents. The Compensation Committee determined that total stockholder return over a three-year period earned 200% of the target, triggering full vesting and immediate settlement.

On the same date, 3,128 shares and 3,929 shares were withheld by the issuer at $19.61 per share to satisfy tax withholding obligations related to restricted stock unit vesting and payout. After these non-market transactions, Flores directly beneficially owned 84,546 shares of common stock, which includes 25,159 stock units that will settle one-for-one in Sabra common shares.

Sabra Health Care REIT, Inc. Executive VP, CIO & Secretary Darrin Smith reported equity-related transactions in the company’s common stock. On January 8, 2026, he acquired 13,710 shares at $0 per share from the vesting of relative total stockholder return-based stock units granted under the 2009 Performance Incentive Plan, including 2,882 shares tied to dividend equivalents. On the same date, the company withheld 5,432 shares at $19.61 per share and another 4,963 shares at $19.61 per share to cover tax obligations related to restricted stock unit vesting and payout. Following these transactions, he directly owned 105,191 shares of common stock, including 32,708 stock units payable share-for-share upon settlement.

Sabra Health Care REIT, Inc. reported an equity award and related tax withholding for its Executive VP, CFO & Treasurer, Michael Lourenco Costa. On January 8, 2026, he acquired 85,690 shares of common stock at $0, reflecting the vesting of total stockholder return-based stock units granted under the company’s 2009 Performance Incentive Plan, including 18,014 shares from dividend equivalents. The compensation committee determined that 200% of the target TSR units were earned over a three-year performance period, and the vested units will be settled one-for-one in common shares on or about January 2, 2027, subject to earlier payment in specified events.

On the same date, 46,132 shares were withheld at $19.61 per share to satisfy tax obligations tied to previously vested restricted stock units. Following these transactions, Costa directly beneficially owned 434,668 common shares, plus indirect holdings of 784 shares in his IRA and 207 shares in his spouse’s IRA. His holdings also include 251,562 stock units payable in an equal number of common shares upon settlement.

Sabra Health Care REIT, Inc. reported insider equity activity for Chair, CEO and President Richard K. Matros. On January 8, 2026, 319,394 shares of common stock vested from relative total stockholder return-based stock units granted on December 27, 2022, including 67,146 shares tied to dividend equivalents. The Compensation Committee determined that TSR units were earned at 200% of target, and the vested units will be settled one-for-one in common shares on or about January 2, 2027, subject to earlier payout upon death, disability or change of control.

The filing also shows 223,944 shares withheld at $19.61 per share to cover tax obligations related to previously vested restricted stock units. In addition, 232,936 shares acquired from previously vested restricted stock units were transferred from Matros directly to the R&A Matros Revocable Trust, which held 1,857,686 shares of common stock after the reported transactions.